KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Johnson & Johnson (JNJ) Restructuring Costs (2016 - 2025)

Johnson & Johnson's Restructuring Costs history spans 12 years, with the latest figure at $84.0 million for Q4 2025.

  • For Q4 2025, Restructuring Costs rose 100.0% year-over-year to $84.0 million; the TTM value through Dec 2025 reached $228.0 million, down 2.56%, while the annual FY2025 figure was $228.0 million, 2.56% down from the prior year.
  • Restructuring Costs for Q4 2025 was $84.0 million at Johnson & Johnson, up from $63.0 million in the prior quarter.
  • Across five years, Restructuring Costs topped out at $252.0 million in Q4 2023 and bottomed at -$13.0 million in Q2 2024.
  • The 5-year median for Restructuring Costs is $64.0 million (2025), against an average of $81.9 million.
  • The largest YoY upside for Restructuring Costs was 592.31% in 2025 against a maximum downside of 89.63% in 2025.
  • A 5-year view of Restructuring Costs shows it stood at $60.0 million in 2021, then increased by 8.33% to $65.0 million in 2022, then soared by 287.69% to $252.0 million in 2023, then plummeted by 83.33% to $42.0 million in 2024, then skyrocketed by 100.0% to $84.0 million in 2025.
  • Per Business Quant, the three most recent readings for JNJ's Restructuring Costs are $84.0 million (Q4 2025), $63.0 million (Q3 2025), and $64.0 million (Q2 2025).